U.S. Rapid Diagnostic Tests (RDT) Market to 2032

Overview

The U.S. Rapid Diagnostic Tests (RDT) Market is expected to reach a 28.19 USD Billion by 2032 and is projected to grow at a CAGR of 14.06% from 2025 to 2032.

Revenue, 2024 (USD Billion)
13.60
Forecast, 2032 (USD Billion)
28.19
CAGR, 2024 - 2032
14.06%
Report Coverage
U.S.

U.S. Rapid Diagnostic Tests (RDT) Market 2018-2032 USD Billion

U.S. Rapid Diagnostic Tests (RDT) Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 13.60 USD Billion
  • Projected Market Size (2032): 28.19 USD Billion
  • CAGR (2025-2032): 14.06%

Key Findings of U.S. Rapid Diagnostic Tests (RDT) Market

  • The U.S. Rapid Diagnostic Tests (RDT) Market was valued at 13.60 USD Billion in 2024.
  • The U.S. Rapid Diagnostic Tests (RDT) Market is likely to grow at a CAGR of 14.06% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Adult in Age Group Segment accounted for the largest share of the market with a revenue of 11.52 USD Billion
  • The fastest growing segment Infections Disease Testing in Application Segment grew Fastest with a CAGR of 16.93% during the forecast period from 2024 to 2032.

U.S. Rapid Diagnostic Tests (RDT) Market Scope

U.S. Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Product Type
  • Others
  • Instruments
  • Consumables and Kits
Technology
  • Others
  • Substrate Technology
  • Microfluidics
  • Agglutination Assay
  • Lateral Flow Immunochromatographic Assays
  • Flow-Through Assays
  • PCR-Based
Mode
  • Over-the-Counter
  • Professional
Application
  • Others
  • Toxicology Testing
  • Pregnancy & Fertility Testing
  • Drugs-Of-Abuse Testing
  • Cardiometabolic Testing
  • Oncology Testing
  • Cardiology Testing
  • Glucose Monitoring
  • Infections Disease Testing
End User
  • Research And Academic Institutes
  • Home Care Setting
  • Others
  • Diagnostic Laboratory
  • Hospital & Clinic
Distribution Channel
  • Retail Sales
  • Direct Tender
Specimen
  • Others
  • Sputum
  • Saliva
  • Urine
  • Blood
  • Swab
Test Type
  • Viral Sequencing
  • Serological Testing
  • Determining Confirmation
Age Group
  • Pediatric
  • Adult
Modality
  • Non-Laboratory Based Test
  • Laboratory Based Test
Approach
  • Molecular Diagnostic
  • In-Vitro Diagnostic

U.S. Rapid Diagnostic Tests (RDT) Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Billion
Market Value in 2024 13.60 USD Billion
Market Value in 2032 28.19 USD Billion
CAGR (2025-2032) 14.06%
Historic Data 2016-2023
Market Segments Covered Product Type, Technology, Mode, Application, End User, Distribution Channel, Specimen, Test Type, Age Group, Modality, Approach

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 13.60 USD Billion in 2024
    • Key Country: U.S., leading in terms of revenue with value of 13,595.86 USD Million in 2024.

Segments and Scope

  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Product Type
    • Consumables and Kits is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 7.65 USD Billion in the year 2024.
    • Consumables and Kits is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.69 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Technology
    • PCR-Based is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 5.07 USD Billion in the year 2024.
    • PCR-Based is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.13 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Mode
    • Professional is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 10.34 USD Billion in the year 2024.
    • Professional is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.36 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Application
    • Infections Disease Testing is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 4.61 USD Billion in the year 2024.
    • Infections Disease Testing is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.93 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By End User
    • Hospital & Clinic is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 7.41 USD Billion in the year 2024.
    • Hospital & Clinic is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.89 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 8.39 USD Billion in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.99 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Specimen
    • Swab is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 6.13 USD Billion in the year 2024.
    • Swab is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 15.82 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Test Type
    • Determining Confirmation is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 5.96 USD Billion in the year 2024.
    • Determining Confirmation is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 16.81 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Age Group
    • Adult is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 11.52 USD Billion in the year 2024.
    • Adult is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.33 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Modality
    • Laboratory Based Test is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 9.67 USD Billion in the year 2024.
    • Laboratory Based Test is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.45 % in forecast period 2025-2032.
  • U.S. Rapid Diagnostic Tests (RDT) Market to 2032, By Approach
    • In-Vitro Diagnostic is the largest segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a revenue of 10.07 USD Billion in the year 2024.
    • In-Vitro Diagnostic is the Fastest growing segment in U.S. Rapid Diagnostic Tests (RDT) Market to 2032 with a Growth rate of 14.58 % in forecast period 2025-2032.

U.S. Rapid Diagnostic Tests (RDT) Market Company Share Analysis

 
Company Name Company Share Analysis
PerkinElmer Inc.
Quidel Corporation
Bio-Rad Laboratories, Inc.
Cardinal Health
Abbott
U.S. Rapid Diagnostic Tests (RDT) Market Company Share Analysis

U.S. Rapid Diagnostic Tests (RDT) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Rapid Diagnostic Tests (RDT) Market Geographical Sales Distribution, 2018-2032 USD Billion

U.S. Rapid Diagnostic Tests (RDT) Market Company Profiling

U.S. Rapid Diagnostic Tests (RDT) Market Company Profiling
Frequently Asked Questions
The U.S. Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Product Type, Technology, Mode, Application, End User, Distribution Channel, Specimen, Test Type, Age Group, Modality, Approach.
U.S. Rapid Diagnostic Tests (RDT) Market was valued at USD 13.60(Revenue in USD Billion) in 2020.
U.S. Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.06% during the forecast period of 2024 to 2032.
The Adult segment is expected to dominate the U.S. Rapid Diagnostic Tests (RDT) Market, holding a largest market share of 11.52 USD Billion in 2024

Coming Soon....

U.S. Rapid Diagnostic Tests (RDT) Market Scope

U.S. Rapid Diagnostic Tests (RDT) Market Segmentation & Scope
Product Type
  • Others
  • Instruments
  • Consumables and Kits
Technology
  • Others
  • Substrate Technology
  • Microfluidics
  • Agglutination Assay
  • Lateral Flow Immunochromatographic Assays
  • Flow-Through Assays
  • PCR-Based
Mode
  • Over-the-Counter
  • Professional
Application
  • Others
  • Toxicology Testing
  • Pregnancy & Fertility Testing
  • Drugs-Of-Abuse Testing
  • Cardiometabolic Testing
  • Oncology Testing
  • Cardiology Testing
  • Glucose Monitoring
  • Infections Disease Testing
End User
  • Research And Academic Institutes
  • Home Care Setting
  • Others
  • Diagnostic Laboratory
  • Hospital & Clinic
Distribution Channel
  • Retail Sales
  • Direct Tender
Specimen
  • Others
  • Sputum
  • Saliva
  • Urine
  • Blood
  • Swab
Test Type
  • Viral Sequencing
  • Serological Testing
  • Determining Confirmation
Age Group
  • Pediatric
  • Adult
Modality
  • Non-Laboratory Based Test
  • Laboratory Based Test
Approach
  • Molecular Diagnostic
  • In-Vitro Diagnostic
Frequently Asked Questions
The U.S. Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Product Type, Technology, Mode, Application, End User, Distribution Channel, Specimen, Test Type, Age Group, Modality, Approach.
U.S. Rapid Diagnostic Tests (RDT) Market was valued at USD 13.60(Revenue in USD Billion) in 2020.
U.S. Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.06% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Rapid Diagnostic Tests (RDT) Market for final year is USD 28.19 (USD Billion).

U.S. Rapid Diagnostic Tests (RDT) Market Company Profiling

U.S. Rapid Diagnostic Tests (RDT) Market Company Profiling
Frequently Asked Questions
The U.S. Rapid Diagnostic Tests (RDT) Market is segmented based on Segmentation Product Type, Technology, Mode, Application, End User, Distribution Channel, Specimen, Test Type, Age Group, Modality, Approach.
U.S. Rapid Diagnostic Tests (RDT) Market was valued at USD 13.60(Revenue in USD Billion) in 2020.
U.S. Rapid Diagnostic Tests (RDT) Market is projected to grow at a CAGR of 14.06% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Rapid Diagnostic Tests (RDT) Market for final year is USD 28.19 (USD Billion).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.